Related Experiment Video
Updated: Jun 19, 2025

10:09
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
8.3K
Oncogenic Roles of UHRF1 in Cancer
Ahhyun Kim1, Claudia A Benavente1,2,3
1Department of Pharmaceutical Sciences, University of California, Irvine, CA 92697, USA.
Epigenomes
|July 25, 2024
Summary
Ubiquitin-like with PHD and RING finger domains 1 (UHRF1) maintains epigenetic stability but is overexpressed in cancers. This review explores UHRF1
Area of Science:
- Epigenetics and Cancer Biology
Background:
- Ubiquitin-like with PHD and RING finger domains 1 (UHRF1) is crucial for maintaining epigenetic marks and stability.
- UHRF1 is implicated in DNA methylation, histone modification, and DNA repair through its functional domains.
- The RB/E2F pathway, frequently deregulated in cancer, controls UHRF1 levels, which are normally cell cycle-dependent and regulated by proteasomal degradation.
Purpose of the Study:
- To review the functional domains of UHRF1.
- To highlight UHRF1's interacting proteins and oncogenic roles in solid tumors.
- To explore therapeutic strategies targeting UHRF1 for potential clinical applications.
Main Methods:
- Literature review focusing on UHRF1's structure, function, and role in cancer.
- Analysis of UHRF1's involvement in epigenetic maintenance and its deregulation in oncogenesis.
- Examination of current and potential therapeutic interventions targeting UHRF1.
Main Results:
- UHRF1 is overexpressed in various cancers, acting as an oncogenic driver.
- Key solid tumors discussed include retinoblastoma, osteosarcoma, lung cancer, and breast cancer.
- UHRF1's functional domains and protein interactions are central to its oncogenic activity.
Conclusions:
- UHRF1 is a significant oncogenic driver in multiple solid tumors due to its overexpression and role in epigenetic dysregulation.
- Targeting UHRF1 domains or its interacting proteins presents promising therapeutic avenues.
- Further research into UHRF1-targeted therapies could lead to novel clinical applications in oncology.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K

